MedPal AI (MPAL) Trading update summary

Pharmacy operations and trading performance

• Processed 28,789 prescription orders in November 2025, generating approximately £280,000 in revenue and achieving over 90% month-on-month growth in prescription volumes.

• Growth driven by successful NHS Distance Selling Pharmacy contract integration and increased uptake of private weight loss services.

• Pharmacy is registered with GPhC and operates with qualified Independent Prescribers under electronic record systems.

Technology deployment and service innovation

• Deployed Google Cloud's Vertex AI on WhatsApp Business, enabling 24/7 AI-powered health assessment and triage for patients.

• Built proprietary machine learning models for clinical triage, seamlessly connecting patients to clinicians for prescriptions.

• Initial focus on weight-loss treatments, with plans to expand to men's and women's health, dermatology, and respiratory care.

ATM facility and funding flexibility

• Established an At-The-Market (ATM) equity issuance facility with Clear Capital, allowing up to £2,000,000 in new share sales over 24 months at a minimum price of 5p per share.

• Facility provides flexible funding to increase stock, expand product lines, and accelerate marketing for pharmacy and clinic growth.

• Share issuances will be controlled to support orderly market conditions, with periodic RNS updates on share sales and proceeds.